MarketMoodz
Insurers Ramp Buybacks — Capital Risks and Rewards
Insurers are repurchasing stock at a scale not seen in recent cycles: Chubb announced a $7.5 billion buyback and Travelers has a $5 billion program with capacity up to $7 billion. The wave lifts earnings per share today but tightens capital buffers—raising questions for ratings agencies, regulators and long-term investors.
Key Takeaways
- Chubb authorized a $7.5 billion share repurchase program.
- Travelers approved $5 billion in buybacks with capacity up to $7 billion.
- Arch Capital has returned roughly $8.5 billion via buybacks over the past 20 years, often near book multiples.
- Reports claim AIG repurchased about 25% of the company over two years at roughly 1x book value, but that figure could not be independently verified.
- Several P&C insurers (Chubb, Hartford, W.R. Berkley) are trading at price-to-book ratios well above their 10-year averages, while Everest Re and RenaissanceRe are buying at discounts to book.
People Involved
- No specific individuals mentioned
Entities Involved
- Chubb Limited (CB)Announced a $7.5 billion buyback program
- The Travelers Companies, Inc. (TRV)Announced $5 billion buyback with capacity up to $7 billion
- American International Group, Inc. (AIG)Reportedly repurchased a large portion of stock over two years (figure unverified)
- Arch Capital Group Ltd. (ACGL)Longstanding repurchaser—around $8.5 billion returned over 20 years
- Progressive Corporation (PGR)Reportedly returned large dividends in late 2025 (figure unverified)
- The Hartford Financial Services Group, Inc. (HIG)Trading at price-to-book above its 10-year average
- W. R. Berkley Corporation (WRB)Trading at price-to-book above its 10-year average
- Everest Re Group, Ltd. (RE)Reported to be buying stock at lower multiples or discounts to book
- RenaissanceRe Holdings Ltd. (RNR)Reported to be buying stock at lower multiples or discounts to book
MarketMoodz Analysis
For investors, buybacks sharpen the tradeoff between near-term shareholder returns and long-term loss-absorbing capacity. Repurchases reduce share count and lift EPS immediately—an attractive lever when premium growth is soft and investment yields remain constrained—but they also shrink statutory and risk-based capital cushions that underwrite underwriting volatility and catastrophe losses. Rating agencies and state regulators watch those capital metrics closely; aggressive or sustained buybacks funded from capital surpluses can prompt scrutiny, and if repurchases are financed by asset sales or leverage the hit to solvency metrics can be material.
Context matters: some insurers have a long history of returning capital—Arch Capital’s multi-decade buyback cadence is a good example—while others are moving quickly as the market softens. Buying at or above book value converts tangible equity into stock that may trade lower after reserve shocks or large catastrophe years, accelerating downside for equity holders. Conversely, firms like Everest Re and RenaissanceRe acquiring shares at discounts to book signal managements that see upside and are preserving capital discipline. Historical cycles show buybacks often peak before underwriting stress or rising catastrophe costs expose reserve weaknesses, so timing and valuation are critical.
Watch three things next: the gap between authorized and executed repurchases (companies often don’t complete authorizations), reserve development and catastrophe payouts that test capital buffers, and commentary from rating agencies or state insurance regulators. Also monitor price-to-book trajectories and whether buybacks are funded from true excess capital versus debt or asset liquidation. Note that several reported figures in the initial coverage could not be independently verified and rely on company releases or market reporting; investors should cross-check SEC filings (8-Ks/10‑Qs/10‑Ks) and capital-ratio disclosures before adjusting allocations.
Source: Original Article